Comparison of the effect of Pharmacologic treatment and Physical therapy on Myofascial Pain Disorders

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210505051187N1

Enrollment

Registered

2021-06-02

Start date

2021-06-05

Completion date

Unknown

Last updated

2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myofascial pain disorders. Other specified disorders of temporomandibular joint

Interventions

Intervention 1: First intervention group: This group is treated with Transcutaneous Electrical Nerve Stimulation device (manufactured by Novin Company) with high frequency and pulse width of 25 mA. Th

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Myofascial Pain Disorders The chief complaint of acute pain (less than 6 months) on at least one side with / without restriction in opening the mouth

Exclusion criteria

Exclusion criteria: Other types of Temporomandibular Disorders Systemic joint diseases (such as Rheumatoid arthritis) A recent history of trauma Complete or partial edentulousness Pregnancy Breastfeeding Patients undergoing orthodontic treatment Patients who are unable to use the desired drugs due to systemic problems Patients who used other treatments

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: At the beginning of the intervention and 10 days after the beginning of the intervention and at the end of the intervention. Method of measurement: The visual Analogue Scale is used to record the amount of pain, which is zero without pain and 10 is the highest amount of pain imaginable for the patient. At each assessment session, the patient should mark their pain on a visual analogue scale.;Maximum mouth opening without pain. Timepoint: At the beginning of the intervention and 10 days after the beginning of the intervention and at the end of the intervention. Method of measurement: Distance between incisal edge of maxillary and mandibular incisors at Maximum mouth opening without pain.	—

Measure

Time frame

Pain. Timepoint: At the beginning of the intervention and 10 days after the beginning of the intervention and at the end of the intervention. Method of measurement: The visual Analogue Scale is used to record the amount of pain, which is zero without pain and 10 is the highest amount of pain imaginable for the patient. At each assessment session, the patient should mark their pain on a visual analogue scale.;Maximum mouth opening without pain. Timepoint: At the beginning of the intervention and 10 days after the beginning of the intervention and at the end of the intervention. Method of measurement: Distance between incisal edge of maxillary and mandibular incisors at Maximum mouth opening without pain.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSahere Soltani

Bojnourd University of Medical Sciences

yasaminmahjoobi75@gmail.com+98 58 3228 9322

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026